Neurocrine Biosciences, Inc. (BVMF:N1BI34)
Brazil · Delayed Price · Currency is BRL 36.33
+0.84 (2.37%)
Last updated: Jan 14, 2026, 2:20 PM GMT-3
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of 71.38 billion as of January 16, 2026. Its market cap has decreased by -17.47% in one year.
Market Cap
71.38B
Enterprise Value
67.97B
Revenue
14.30B
Ranking
n/a
PE Ratio
31.29
Stock Price
36.33
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 206.46M to 71.38B, an increase of 34,474.65%. That is a compound annual growth rate of 21.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 71.38B | -8.36% |
| Dec 31, 2025 | 77.89B | -8.88% |
| Dec 31, 2024 | 85.48B | 36.07% |
| Dec 29, 2023 | 62.82B | 3.48% |
| Dec 30, 2022 | 60.70B | 34.84% |
| Dec 31, 2021 | 45.02B | -3.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 88.98B |
| Raia Drogasil | 42.46B |
| Hypera | 14.95B |
| Fleury | 8.48B |
| Odontoprev | 5.76B |
| Diagnósticos da América | 4.76B |
| Empreendimentos Pague Menos | 4.26B |
| Blau Farmacêutica | 2.71B |